DegenRx B.V.
PrivateLast Round
Grant
Jun 4, 2019
Company Overview
DegenRx B.V. operates in Healthcare & Life Sciences and is based in Tilburg. Its latest recorded funding round was a Grant round in June 2019.
DegenRx B.V. is a biotechnology company developing AAV-mediated gene therapy for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DegenRx B.V. Comparables
Compare DegenRx B.V. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AviadoBio | 84% | |
| Klogene Therapeutics, Inc. | 83% | |
| Capsida Biotherapeutics | 76% |
For institutional investors. Book with your work email.
DegenRx B.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 4, 2019 | ||||
| Series A | Dec 21, 2018 |
For institutional investors. Book with your work email.
DegenRx B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Swanbridge Capital | Series A |
| BOM Brabant Ventures | Series A |
| Health~Holland | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2019
Received grant funding from Health~Holland.
- Dec 21, 2018
Raised Series A with BOM Brabant Ventures and Swanbridge Capital.
For institutional investors. Book with your work email.
DegenRx B.V. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DegenRx B.V.'s valuation, stock price, and market status.
Is DegenRx B.V. a public or private company?
DegenRx B.V. is a private company.
What is the current stock price of DegenRx B.V.?
DegenRx B.V. is a private company, so its shares have no public market price. Caplight tracks DegenRx B.V.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DegenRx B.V. worth (valuation)?
Valuation information for DegenRx B.V. is not publicly available.
Can I buy DegenRx B.V. stock?
DegenRx B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DegenRx B.V.'s last funding round?
DegenRx B.V.'s most recent funding round was Grant on June 4, 2019.
Who are the main investors in DegenRx B.V.?
Key investors in DegenRx B.V. include Swanbridge Capital, BOM Brabant Ventures, Health~Holland.
Will DegenRx B.V. IPO soon?
No public IPO plans have been announced for DegenRx B.V..
How can I track DegenRx B.V. secondary market activity?
Caplight tracks bids, offers, and trades in DegenRx B.V.'s shares on secondary markets.